Research Article
Oxidative Modification of Blood Serum Proteins in Multiple Sclerosis after Interferon Beta and Melatonin Treatment
Figure 5
Comparison of AGE content of blood serum proteins in healthy controls, in RRMS patients without treatment, in RRMS patients treated with INF-beta, and in RRMS patients treated with INF-beta and MEL.